Skip to content
Search AI Powered

Latest Stories

Pharmacy bodies welcome extension of death in service benefit to pharmacy staff

The Royal Pharmaceutical Society (RPS) has welcomed the government’s latest clarification  that the death in service benefit for frontline NHS key workers has now been extended to pharmacy teams.

In a letter sent to RPS President Sandra Gidley last week, Secretary of State for Health and Social Care Matt Hacock wrote: "I absolutely recognise the vital contribution of community pharmacy staff as a frontline service and the increased risks that community pharmacy staff may face where they are providing close personal healthcare," as he confirmed that the death in service benefit will now cover the entire pharmacy staff.


The scheme, which was limited to frontline NHS key workers, will now include pharmacists, pharmacy technicians, dispensing assistants and counter assistants.

Commenting on the confirmation, Gidley said: “We have consistently fought for all of the pharmacy team to be included in this scheme. The original omission of pharmacists and their much-valued colleagues from the benefit was a body blow for all of us.

“We are very pleased to have now received personal reassurances from Matt Hancock that the whole pharmacy family will now be eligible to make a claim under the scheme. Frontline pharmacy teams have shown extraordinary dedication to their patients and the NHS during the pandemic.

“Pharmacies are one of the few places where patients can still get face-to-face advice and treatment, and as such are exposed to increased risks. It’s only right that such commitment is recognised should the very worst happen.”

The scheme is non-contributory and pays a £60,000 lump sum.

A frontline worker needs to fulfill the following criteria to secure  benefit under the new life assurance scheme.

  • The individual was employed in a role covered by the scheme
  • It can be established that in the 14 days before symptoms emerged, the individual had been working in environments or locations where personal care is provided to patients or service users who have, or were suspected to have, contracted coronavirus
  • The nature of the work they did led to a increased risk of contracting coronavirus
  • Coronavirus was the cause of or a contributory factor in the death.

“It recognises that frontline health and social care staff are working in environments where direct personal healthcare is provided to patients and service users who have or are suspected to have Covid-19,” Hancock wrote in the letter which was also sent to President of the Association of Pharmacy Technicians Liz Fidler.

Giving her reaction, Fidler said: “The clarification from the Secretary of State that Pharmacy Technicians, Dispensers and Medicines Counter Assistants are included in the Governments Life Assurance Scheme is extremely welcome.”

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less